InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Tango Therapeutics, Inc.

TNGX Clue Score51
United States Fiscal year ends December CIK 0001819133 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Jessica Newcomb
2 Nov 2026
Principal Accounting Officer
Sold on a plan
1,460
$22.98
$33.55K
Jessica Newcomb
2 Nov 2026
Principal Accounting Officer
Sold on a plan
5,571
$22.28
$124.11K
Jessica Newcomb
22 Sep 2026
Principal Accounting Officer
Sold on a plan
2,400
$25.17
$60.41K
Jessica Newcomb
22 Sep 2026
Principal Accounting Officer
Sold on a plan
5,100
$23.97
$122.24K
Jessica Newcomb
22 Sep 2026
Principal Accounting Officer
Sold on a plan
700
$22.80
$15.96K
Adam Crystal
5 Mar 2026
President, R&D
Sold on a plan
20,251
$15.00
$303.77K
Adam Crystal
25 Feb 2026
President, R&D
Sold on a plan
54,345
$12.77
$694.21K
Show all 29 transactions →

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 16
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 804,382
History held since 10 Sep 2020